DUBLIN--(BUSINESS WIRE)--The "Central Nervous System (CNS) Biomarkers: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global CNS biomarker market was valued at $5.7 billion in 2022. The market is projected to reach $9.5 billion in 2027, growing at a CAGR of 10.8% duri...